Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 120.17B | 120.66B | 120.98B | 107.63B | 101.90B | 105.79B |
Gross Profit | 9.84B | 10.21B | 9.58B | 7.37B | 8.40B | 10.38B |
EBITDA | 3.56B | 5.97B | 3.90B | 3.68B | 3.92B | 5.99B |
Net Income | 1.81B | 3.50B | 2.74B | 2.25B | 1.81B | 3.22B |
Balance Sheet | ||||||
Total Assets | 195.31B | 206.76B | 203.61B | 155.75B | 155.10B | 153.36B |
Cash, Cash Equivalents and Short-Term Investments | 25.82B | 12.54B | 17.49B | 17.58B | 33.70B | 48.82B |
Total Debt | 33.40B | 36.90B | 33.49B | 13.60B | 13.71B | 13.36B |
Total Liabilities | 100.29B | 109.89B | 110.69B | 76.53B | 80.80B | 78.76B |
Stockholders Equity | 95.02B | 96.87B | 92.93B | 79.22B | 74.30B | 74.61B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -8.05B | -22.97B | -16.25B | -14.24B | 20.50B |
Operating Cash Flow | 0.00 | -7.73B | -22.39B | -2.91B | -13.72B | 21.26B |
Investing Cash Flow | 0.00 | -26.00M | 2.67B | -12.98B | -1.41B | -716.00M |
Financing Cash Flow | 0.00 | 2.66B | 19.30B | -696.00M | -394.00M | -948.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥23.73B | 7.91 | 1.20% | -14.89% | -28.68% | ||
80 Outperform | ¥34.61B | 12.03 | 5.82% | 2.36% | 136.83% | ||
74 Outperform | ¥24.85B | 8.56 | 3.04% | 2.91% | 9.79% | ||
72 Outperform | ¥30.76B | 8.78 | 2.79% | -0.26% | 28.01% | ||
71 Outperform | ¥23.76B | 7.41 | 2.64% | -4.84% | -16.53% | ||
66 Neutral | ¥34.63B | 15.67 | 2.64% | 2.37% | 10.22% | ||
65 Neutral | $10.65B | 15.52 | 5.51% | 1.92% | 2.72% | -26.34% |